FDA and industry actions on premarket notification (510(k)) submissions, effect on FDA review clock and performance assessment.
Other author/creator | Center for Devices and Radiological Health (U.S.) |
Other author/creator | Center for Biologics Evaluation and Research (U.S.) |
Format | Electronic and Book |
Publication Info | Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Devices and Radiological Health : Center for Biologics Evaluation and Research, [2004] |
Description | 14 p. : digital, PDF file |
Supplemental Content | https://purl.fdlp.gov/GPO/LPS113026 |
Subject(s) |
Click here for more information about this title
Variant title | At head of title: Guidance for industry and FDA staff |
General note | Title from PDF title page (viewed on May 22, 2009). |
General note | "Document issued on: May 21, 2004". |
General note | GPO Cataloging Record Distribution Program (CRDP). |
Technical details | Mode of access: Internet at the FDA CBER web site. Address as of 5/22/09: http://www.fda.gov/cdrh/mdufma/guidance/1219.pdf ; current access is available via PURL. |
GPO item number | 0499-T-02 (online) |
Govt. docs number | HE 20.4802:F 73/2 |
Available Items
Library | Location | Call Number | Status | Item Actions | |
Joyner | Electronic Resources | Access Content Online | ✔ Available |